How accurate are continuum solvation models for drug-like molecules?

被引:63
|
作者
Kongsted, Jacob [2 ]
Soderhjelm, Par [1 ]
Ryde, Ulf [1 ]
机构
[1] Lund Univ, Dept Theoret Chem, Ctr Chem, S-22100 Lund, Sweden
[2] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark
基金
瑞典研究理事会;
关键词
Solvation energy; Free energy of hydration; Continuum methods; PCM; Langevin dipoles; FDPB; Generalised Born; HYDRATION FREE-ENERGIES; GENERALIZED BORN MODEL; REACTION FIELD; ATOMIC CHARGES; CONFORMATIONAL-ANALYSIS; DYNAMICS SIMULATIONS; CHEMICAL-PROCESSES; QUANTUM-MECHANICS; CONDENSED-PHASE; ORBITAL METHOD;
D O I
10.1007/s10822-009-9271-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have estimated the hydration free energy for 20 neutral drug-like molecules, as well as for three series of 6-11 inhibitors to avidin, factor Xa, and galectin-3 with four different continuum solvent approaches (the polarised continuum method the Langevin dipole method, the finite-difference solution of the Poisson equation, and the generalised Born method), and several variants of each, giving in total 24 different methods. All four types of methods have been thoroughly calibrated for a number of experimentally known small organic molecules with a mean absolute deviation (MAD) of 1-6 kJ/mol for neutral molecules and 4-30 kJ/mol for ions. However, for the drug-like molecules, the accuracy seems to be appreciably worse. The reason for this is that drug-like molecules are more polar than small organic molecules and that the uncertainty of the methods is proportional to the size of the solvation energy. Therefore, the accuracy of continuum solvation methods should be discussed in relative, rather than absolute, terms. In fact, the mean unsigned relative deviations of the best solvation methods, 0.09 for neutral and 0.05 for ionic molecules, correspond to 2-20 kJ/mol absolute error for the drug-like molecules in this investigation, or 2-3,000 in terms of binding constants. Fortunately, the accuracy of all methods can be improved if only relative energies within a series of inhibitors are considered, especially if all of them have the same net charge. Then, all except two methods give MADs of 2-5 kJ/mol (corresponding to an uncertainty of a factor of 2-7 in the binding constant). Interestingly, the generalised Born methods typically give better results than the Poison-Boltzmann methods.
引用
收藏
页码:395 / 409
页数:15
相关论文
共 50 条
  • [41] A potentiometric titration method for the crystallization of drug-like organic molecules
    Du-Cuny, Lei
    Huwyler, Joerg
    Fischer, Holger
    Kansy, Manfred
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 342 (1-2) : 161 - 167
  • [42] A structure-permeability study of small drug-like molecules
    Fichert, T
    Yazdanian, M
    Proudfoot, JR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 719 - 722
  • [43] Generative Network Complex for the Automated Generation of Drug-like Molecules
    Gao, Kaifu
    Duc Duy Nguyen
    Tu, Meihua
    Wei, Guo-Wei
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5682 - 5698
  • [44] Efficient and accurate solvation energy calculation from polarizable continuum models
    Lin, Shiang-Tai
    Hsieh, Chieh-Ming
    [J]. JOURNAL OF CHEMICAL PHYSICS, 2006, 125 (12):
  • [45] Automation of the Charmm General Force Field for Drug-Like Molecules
    Vanommeslaeghe, Kenno
    Ghosh, Jayeeta
    Polani, Narendra K.
    Sheetz, Michael
    Pamidighantam, Sudhakar V.
    Connolly, John W. D.
    MacKerell, Alexander D., Jr.
    [J]. BIOPHYSICAL JOURNAL, 2011, 100 (03) : 611 - 611
  • [46] Modeling quinone formation of drug-like molecules with machine learning
    Hughes, Tyler B.
    Le Dang, Na
    Swamidass, S. Joshua
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 107 - 107
  • [47] Lead-like, drug-like or “Pub-like”: how different are they?
    Tudor I. Oprea
    Tharun Kumar Allu
    Dan C. Fara
    Ramona F. Rad
    Lili Ostopovici
    Cristian G. Bologa
    [J]. Journal of Computer-Aided Molecular Design, 2007, 21 : 113 - 119
  • [48] Lead-like, drug-like or "pub-like": How different are they?
    Oprea, Tudor I.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
  • [49] Lead-like, drug-like or "pub-like": how different are they?
    Oprea, Tudor I.
    Allu, Tharun Kumar
    Fara, Dan C.
    Rad, Ramona F.
    Ostopovici, Lili
    Bologa, Cristian G.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2007, 21 (1-3) : 113 - 119
  • [50] Computer-based de novo design of drug-like molecules
    Schneider, G
    Fechner, U
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (08) : 649 - 663